• Patient-Derived Gastric Cancer Assembloids Reveal Drug Resis

  2026-08-05

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, enabling a more faithful recreation of tumor heterogeneity and microenvironmental influences. The findings highlight how stromal components shape gene expression and drug responses, providing a robust platform for investigating resistance mechanisms and optimizing personalized therapies.

• Senolytic Actions of L. plantarum DS0037 Nanovesicles in Cel

  2026-08-05

  This study introduces exosome-like nanovesicles derived from Lactobacillus plantarum DS0037 as selective senolytic and senomorphic agents targeting aging cells. Their ability to suppress senescent cell viability and modulate pro- and anti-aging gene expression highlights potential applications in anti-aging research and functional skincare.

• Magnetic Stimulation Downregulates GABAA ε to Reverse SCZ Be

  2026-08-04

  This study demonstrates that combined magnetic stimulation system treatment (c-MSST) precisely targeting the left prelimbic cortex downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits in mouse models. The findings identify Gabre as a mechanistic node for intervention, offering new insights for both neuromodulation and pharmacological strategies in schizophrenia research.

• Bobcat339: Applied Protocols for TET Inhibition in Epigeneti

  2026-08-04

  Bobcat339 empowers precise interrogation of TET1/2-driven DNA methylation in disease-relevant models. Discover actionable workflows and troubleshooting insights for translating epigenetic regulatory mechanism studies into robust, reproducible results.

• GET3 Controls MCL1-Mediated Apoptosis via Tail-Anchoring Mec

  2026-08-03

  This study uncovers a direct regulatory axis between the GET3 tail-anchor insertion pathway and the anti-apoptotic protein MCL1, revealing how GET3 modulates mitochondrial apoptosis through MCL1 membrane targeting. These insights refine our understanding of apoptosis regulation during mitotic arrest and highlight mechanistic vulnerabilities that may be exploited in hematological cancer research.

• IPR-803: Urokinase Receptor Inhibitor for Tumor Invasion Ass

  2026-08-03

  IPR-803 is a highly specific urokinase receptor inhibitor, uniquely designed to disrupt the uPAR–uPA interaction central to tumor invasion and metastasis. Its robust utility in both breast and pancreatic cancer models, along with nanomedicine compatibility, makes it a go-to tool for translational oncology research and metastasis inhibition.

• ECL Western Blotting Substrate: Practical Use & Protocol Gui

  2026-08-02

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of HRP-conjugated proteins in chemiluminescent Western blot assays. It is suitable for protein detection in molecular and cancer biology, but should not be used for fluorescent or radioisotopic workflows.

• Glucocorticoid Receptor-Mediated CYP Suppression in Neuropro

  2026-08-01

  This study reveals that pregnenolone 16α-carbonitrile (PCN) suppresses hippocampal cytochrome P450 expression and attenuates phenytoin-induced neurotoxicity via a glucocorticoid receptor-dependent, PXR-independent mechanism. The findings uncover a novel pathway for reducing adverse neurological effects of antiepileptic therapy and provide mechanistic insight into neurosteroid metabolism regulation.

• Baicalin Methyl Ester Restores Intestinal Barrier via P65/TN

  2026-07-31

  This study demonstrates that baicalin methyl ester (BME) protects against LPS-induced intestinal barrier damage in mice and MODE-K cells by modulating the P65/TNF-α/MLCK/ZO-1 signaling axis. The findings provide mechanistic insight into maintaining mucosal integrity during inflammatory insults and highlight the potential of tight junction regulation in gastrointestinal disease models.

• Patient-Derived Gastric Cancer Assembloids Enhance Drug Test

  2026-07-31

  This study introduces a gastric cancer assembloid platform that integrates matched tumor organoids and stromal cell subpopulations, closely mimicking the primary tumor microenvironment. The approach improves physiological relevance in preclinical drug screening, highlights stromal modulation of drug response, and enables deeper investigation of resistance mechanisms.

• Nanoplastics and Cadmium Co-exposure Triggers Intestinal Apo

  2026-07-30

  This study demonstrates that co-exposure to polystyrene nanoplastics and cadmium induces apoptosis in intestinal cells by activating the IP3R/Ca2+/STAT3 signaling pathway. The findings clarify mechanistic links between environmental co-contaminants and highlight calcium signaling modulation as a strategic target for apoptosis research.

• Magnetic Stimulation Downregulates GABAA-ε to Reverse Schizo

  2026-07-30

  This study demonstrates that selective magnetic stimulation of the left prelimbic cortex in mice downregulates the GABAA receptor epsilon subunit, reversing schizophrenia-like behaviors and synaptic deficits. The findings reveal new neuromodulatory mechanisms and identify GABRE as a promising molecular target for translational schizophrenia research.

• Ivermectin as a Broad-Spectrum Anti-Parasitic in Tumor Resea

  2026-07-29

  Ivermectin’s unique mechanistic profile and robust solubility make it a versatile anti-parasitic research compound for both classical parasitology and cutting-edge tumor microenvironment studies. Discover stepwise workflows and troubleshooting strategies, with insights from the latest Gasdermin C-driven pancreatic cancer research.

• Microglial Activation Drives Synaptic Imbalance in Alcohol S

  2026-07-29

  This paper reveals how acute alcohol exposure activates microglia in the hippocampal CA1 region, leading to altered synaptic formation and increased seizure susceptibility. The findings clarify the mechanistic link between microglial neuroinflammation, GABAergic/glutamatergic imbalance, and alcohol-induced seizures, providing a basis for targeted intervention strategies.

• Lipid Scrambling in Ferroptosis: TMEM16F as a Tumor Immunity

  2026-07-28

  Yang et al. reveal that TMEM16F-mediated lipid scrambling at the plasma membrane suppresses ferroptosis and enables tumor cells to evade immune rejection. Their findings highlight lipid remodeling as a crucial checkpoint in ferroptosis execution and suggest new strategies for cancer immunotherapy.

15858 records 1/1058 page Next 12345 下5页 Last page